Icade S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDMGF research report →
Price Chart
About the company
Icade S. A. operates as a holistic real estate enterprise, adeptly combining the roles of both investor and developer.
- CEO
- Nicolas Joly
- IPO
- 2011
- Employees
- 1,007
- HQ
- Issy-les-Moulineaux, IF, FR
Get TickerSpark's AI analysis on CDMGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.53B
- P/E
- -7.53
- Fwd P/E
- 7.02
- PEG
- 0.21
- P/S
- 1.01
- P/B
- 0.40
- EV/EBITDA
- -63.82
- Div Yield
- 10.32%
- Gross Margin
- 23.26%
- Op Margin
- 16.91%
- Net Margin
- -13.41%
- ROE
- -5.03%
- ROIC
- 2.64%
Latest fiscal year · YoY change
- Revenue
- $1.45B-0.2%
- Gross Profit
- $352.17M-29.8%
- Op Income
- $276.30M
- Net Income
- $-122,953,931+55.4%
- EPS
- $-1.63+55.2%
- OCF Growth
- -2.7%
- FCF Growth
- -69.3%
- 52W High
- $26.44
- 52W Low
- $20.15
- 50D MA
- $21.19
- 200D MA
- $23.57
- Beta
- 0.85
- RSI (14)
- 0
- Avg Volume
- 12
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Icade delivered a resilient H1 with disposals and leasing progress, but earnings and NAV were lower as the company faces a challenging real estate backdrop and expects 2026 to be the low point for strategic cash flow.· July 22, 2026
- Marignan was sold for EUR 402 million, and a Portuguese healthcare portfolio disposal was signed with Icade exposure of about EUR 75 million.
- Operating performance held up: close to 94,000 sq m were signed or renewed, financial occupancy rose to 85.9%, and office occupancy was close to 90%.
- H1 group net current cash flow was EUR 1.80 per share versus EUR 2.03 a year ago; strategic net current cash flow was EUR 1.15 per share versus EUR 1.44.
- NAV NCA per share was EUR 49.7, down 6.9% from year-end 2025, while LTV including duties improved to 39%.
- Management confirmed full-year 2026 guidance of EUR 2.90 to EUR 3.10 per share and said 2026 should mark the low point for strategic cash flows.
Reported H1 2026 group net current cash flow was EUR 1.80 per share, versus EUR 2.03 in H1 2025. Strategic operations contributed EUR 1.16 per share, down from EUR 1.44 a year earlier. Property investment gross rental income was EUR 170.2 million, down 4.5% reported and 1.1% like-for-like. Property development economic revenue was EUR 473 million, down 5.5% year over year, and the current economic operating margin was 1.9% versus 2.3% in H1 2025. NAV NCA per share was EUR 49.7, down 6.9% versus year-end 2025; LTV including duties improved to 39% from 39.6%, net debt/EBITDA was 9.2x, and average cost of debt rose to 1.85%. Liquidity was EUR 2.5 billion. For 2026, management reiterated group net current cash flow guidance of EUR 2.90 to EUR 3.10 per share, including EUR 2.25 to EUR 2.45 per share from strategic operations and about EUR 0.65 per share from discontinuing operations. Management also said the average cost of debt should be around 2% by year-end.
Nicolas Joly emphasized disciplined capital allocation, selective disposals, and active asset management as the core of the strategy. He said the group is willing to wait for the right pricing window, citing Marignan and the Portuguese healthcare transaction, and highlighted Eqho’s full occupancy and the launch of new partnerships in student housing and office-to-residential conversion. His tone was cautious on the macro, with repeated references to persistent uncertainty, high rates, and a weak leasing and investment market.
Bruno Valentin focused on the bridge from H1 cash flow to full-year guidance and the financial discipline behind it. He said strategic net current cash flow was EUR 1.16 per share, with headwinds from property investment income, lower development contribution, and finance expense, partly offset by lower operating costs; he also noted a EUR 6.5 million reduction in costs in H1. On the balance sheet, he pointed to EUR 2.5 billion of liquidity, the EUR 150 million green bond due 2035, the renewal of EUR 450 million of revolving credit, a 1.85% average cost of debt, 97% hedging for H2 2026, and more than 85% hedged through 2028.
Analysts focused on valuation assumptions, office rental losses from departures, the sustainability of like-for-like rental trends, development margins, and the strategic logic of Eqho. Management said office values were still under pressure from yields and that they are waiting for more market transactions to confirm the trough; they also said 2026 lease departures are built into guidance and that 2027 visibility is better, with roughly 75% of expiring revenues expected to stay. On Eqho, they said the tower was acquired at an over-8% yield, is now fully let, needs no major near-term CapEx, and should be accretive to cash flow. They also said S&P kept a BBB rating with negative outlook in June and that they are focused on improving operational KPIs.
The call showed real execution on disposals, leasing, and portfolio reshaping: Marignan was monetized at a premium to NAV, Eqho is now fully owned and fully let, and the Portuguese healthcare sale is progressing. Occupancy improved, WALT increased to four years, and management sees residential margins gradually recovering as the mix shifts toward better-quality projects and new partnerships open future growth avenues.
Management was explicit that the environment remains tough: asset values are still falling, office rents face negative reversion and departures, and development margins are only gradually improving. H1 cash flow declined year over year, the portfolio valuation was down, and management expects finance costs to keep rising toward about 2% by year-end, with no strong recovery in development margins expected before 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 59.7%
- Shares Outstanding
- 75.80M
- Float Shares
- 45.26M
Our CDMGF coverage
Recent articles, reports, and earnings notes.
No research on CDMGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CDMGF report →Icade (CDMGF) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 22
Icade (CDMGF) Q1 2026 Sales/Trading Call Transcript
seekingalpha.com · Apr 17
Icade (CDMGF) Q4 2025 Earnings Call Transcript
seekingalpha.com · Feb 18
Icade (CDMGF) Q3 2025 Earnings Call Transcript
seekingalpha.com · Oct 23
Icade (CDMGF) Q2 2025 Earnings Call Transcript
seekingalpha.com · Jul 24
Icade Remains A Trap Following Recent Earnings
seekingalpha.com · May 13
Icade (CDMGF) Q1 2025 Earnings Call Transcript
seekingalpha.com · Apr 17
Casino Group: Icade makes a first acquisition of 9 sites from Casino Group
globenewswire.com · Mar 31
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.